Endovascular Treatment for eXtra-Large Ischemic Stroke

Recruiting N/A Interventional Study
Stroke, Acute Ischemic
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
286 (estimated)
Sponsor
Zhongming Qiu · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The role of endovascular thrombectomy in patients with extra-large ischemic burden is still unclear. The XL STROKE-2 randomized trial is aiming to investigate the efficacy and safety of mechanical thrombectomy in acute extra-large ischemic stroke patients with large vessel occlusion.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age 18 years or older, and modified Rankin scale score = 0 or 1 in patients 80 years or older; 2. Acute ischemic stroke within 6 hours from last known well to randomization, or with negative MRI-FLAIR (no change on FLAIR sequence and presence of infarct on MRI-DWI) if \> 6 ho…
Contacts

Zhongfan Ruan

15616320002

ruanzhongfan@sina.com

CONTACT

Zhongming Qiu

13236599269

qiuzhongmingdoctor@163.com

CONTACT